Publication:
Research Directions in Genetic Predispositions to Stevens–Johnson Syndrome / Toxic Epidermal Necrolysis

Issued Date

2018-03-01

Resource Type

Article

ISSN

15326535
00099236

DOI

10.1002/cpt.890

Other identifier(s)

2-s2.0-85041800780

Rights

Mahidol University

Rights Holder(s)

SCOPUS

Bibliographic Citation

Clinical Pharmacology and Therapeutics. Vol.103, No.3 (2018), 390-394

Suggested Citation

Teri A. Manolio, Carolyn M. Hutter, Mark Avigan, Ricardo Cibotti, Robert L. Davis, Joshua C. Denny, Lois La Grenade, Lisa M. Wheatley, Mary N. Carrington, Wasun Chantratita, Wen Hung Chung, Andrea D. Dalton, Shuen Iu Hung, Ming Ta Michael Lee, J. Steven Leeder, Juan J.L. Lertora, Surakameth Mahasirimongkol, Howard L. McLeod, Maja Mockenhaupt, Michael Pacanowski, Elizabeth J. Phillips, Simone Pinheiro, Munir Pirmohamed, Cynthia Sung, Wimon Suwankesawong, Lauren Trepanier, Santa J. Tumminia, David Veenstra, Rika Yuliwulandari, Neil H. Shear Research Directions in Genetic Predispositions to Stevens–Johnson Syndrome / Toxic Epidermal Necrolysis. Clinical Pharmacology and Therapeutics. Vol.103, No.3 (2018), 390-394. doi:10.1002/cpt.890 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/46933

Research Projects

Organizational Units

Authors

Journal Issue

Thesis

Title

Research Directions in Genetic Predispositions to Stevens–Johnson Syndrome / Toxic Epidermal Necrolysis

Author(s)

Teri A. Manolio
 Carolyn M. Hutter
 Mark Avigan
 Ricardo Cibotti
 Robert L. Davis
 Joshua C. Denny
 Lois La Grenade
 Lisa M. Wheatley
 Mary N. Carrington
 Wasun Chantratita
 Wen Hung Chung
 Andrea D. Dalton
 Shuen Iu Hung
 Ming Ta Michael Lee
 J. Steven Leeder
 Juan J.L. Lertora
 Surakameth Mahasirimongkol
 Howard L. McLeod
 Maja Mockenhaupt
 Michael Pacanowski
 Elizabeth J. Phillips
 Simone Pinheiro
 Munir Pirmohamed
 Cynthia Sung
 Wimon Suwankesawong
 Lauren Trepanier
 Santa J. Tumminia
 David Veenstra
 Rika Yuliwulandari
 Neil H. Shear

Other Contributor(s)

Leidos Inc.
 National Yang-Ming University Taiwan
 Chang Gung Memorial Hospital
 Universität Freiburg im Breisgau
 University of Wisconsin Madison, School of Veterinary Medicine
 Massachusetts Institute of Technology
 The Food and Drug Administration, Thailand Ministry of Public Health
 University of Liverpool
 Chang Gung University
 Murdoch University
 Children's Mercy Hospitals and Clinics
 National Institute of Allergy and Infectious Diseases
 National University of Singapore
 University of Toronto
 NIH Clinical Center
 Faculty of Medicine, Ramathibodi Hospital, Mahidol University
 Thailand Ministry of Public Health
 University of Washington, Seattle
 National Human Genome Research Institute
 Food and Drug Administration
 Geisinger Health System
 National Eye Institute
 National Institute of Arthritis and Musculoskeletal and Skin Diseases
 Moffitt Cancer Center
 Vanderbilt University
 University of Tennessee Health Science Center
 Stevens-Johnson Syndrome Foundation
 YARSI University

Abstract

© 2017 American Society for Clinical Pharmacology and Therapeutics Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is one of the most devastating of adverse drug reactions (ADRs) and was, until recently, essentially unpredictable. With the discovery of several risk alleles for drug-induced SJS/TEN and the demonstration of effectiveness of screening in reducing incidence, the stage is set for implementation of preventive strategies in populations at risk. Yet much remains to be learned about this potentially fatal complication of commonly used drugs.

Keyword(s)

Medicine
 Pharmacology, Toxicology and Pharmaceutics

Availability

URI

https://repository.li.mahidol.ac.th/handle/20.500.14594/46933

Collections

Scopus 2018